Gut Microbiome Analysis Can Predict Parkinson's Disease Risk Before Symptoms Appear

University College London researchers have published a study in Nature Medicine demonstrating that gut microbiome analysis can identify elevated Parkinson's disease risk before symptoms develop. The research reveals that both people with Parkinson's disease and healthy individuals genetically predisposed to the condition share a distinctive makeup of gut microbes. This discovery enables analysis of gut microbes to reveal whether a person faces elevated Parkinson's risk, potentially opening pathways for early intervention strategies before the disease manifests clinically.

Gut Microbiome as Predictor of Parkinson's Risk

• ▪Healthy individuals who are genetically at risk of Parkinson's disease have a distinctive makeup of gut microbes.
• ▪A new study on gut microbiome and Parkinson's disease was led by University College London (UCL) researchers.
• ▪People with Parkinson's disease have a distinctive makeup of gut microbes.
• ▪The University College London study on gut microbiome and Parkinson's disease was published in Nature Medicine.
• ▪Analysis of microbes in the gut can reveal whether a person faces an elevated risk of Parkinson's disease.

Detection Before Symptom Onset in At-Risk Individuals

• ▪Gut microbiome analysis can reveal elevated Parkinson's disease risk before a person has developed any symptoms.

Perspective of University College London researchers

• ▪Gut microbiome analysis offers potential for early intervention in Parkinson's disease before symptoms appear.
• ▪The distinctive gut microbe makeup in at-risk individuals could enable preventive strategies for Parkinson's disease.

1 source